Literature DB >> 33826128

Clinical impact of quantitative [15O] H2O PET/CT myocardial perfusion imaging on decision-making regarding invasive management of coronary artery disease.

Chetsadaporn Promteangtrong1, Attapon Jantarato2, Anchisa Kunawudhi2, Peerapon Kiatkittikul2, Dheeratama Siripongsatian2, Natphimol Boonkawin2, Chanisa Chotipanich2.   

Abstract

BACKGROUND: This study was performed to determine the impact of oxygen-15-labeled water ([15O] H2O) positron emission tomography/computed tomography (PET/CT) myocardial perfusion imaging (MPI) on referral for invasive coronary angiography (ICA) and revascularization.
METHODS: This study involved 57 patients who underwent [15O] H2O PET/CT MPI for evaluation of coronary artery disease (CAD). Data of referral for ICA and revascularization, clinical symptoms, and cardiac events within 6 months after MPI were assessed. Logistic regression was used to determine the predictors for referral and revascularization. The diagnostic values of hyperemic myocardial blood flow (MBF) and coronary flow reserve (CFR) were calculated.
RESULTS: Normal and abnormal MPI findings were observed in 18 (32%) and 39 (68%) patients, respectively. The referral rate was significantly different between the normal and abnormal MPI groups (5.6% and 48.7%, respectively; P = .002). Revascularization rate of abnormal MPI group was 40.0%. There were significant differences of hyperemic MBF and CFR between patients with and without referral. Hyperemic MBF was significant predictor for referral (OR 15.24, 95% CI 3.39-68.55, P < .005) and revascularization (OR 28.57, 95% CI 3.08-265.33, P < .005).
CONCLUSION: [15O] H2O PET/CT MPI showed a clinical impact on decision-making regarding invasive procedure for management of CAD.
© 2021. American Society of Nuclear Cardiology.

Entities:  

Mesh:

Year:  2021        PMID: 33826128     DOI: 10.1007/s12350-021-02604-y

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   3.872


  1 in total

Review 1.  PET tracers and techniques for measuring myocardial blood flow in patients with coronary artery disease.

Authors:  Bailing Hsu
Journal:  J Biomed Res       Date:  2013-09-25
  1 in total
  1 in total

1.  Combining body mass index with waist circumference to assess coronary microvascular function in patients with non-obstructive coronary artery disease.

Authors:  Shihao Huangfu; Qi Yao; Ruonan Wang; Xiang Li; Ping Wu; Zhifang Wu; Li Li; Yuetao Wang; Minfu Yang; Marcus Hacker; Haitao Zhou; Rui Yan; Sijin Li
Journal:  J Nucl Cardiol       Date:  2021-09-03       Impact factor: 3.872

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.